Leiomyoma clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, not yet accepting patients
The PLUM Study is a randomized, double-blinded, 2-arm, parallel-group, placebo-controlled trial is designed to compare the efficacy of letrozole versus placebo on leiomyoma-related symptoms and quality of life as well as leiomyoma and uterine size.
San Francisco, California and other locations
Our lead scientists for Leiomyoma research studies include Vanessa Jacoby, MD, MAS.